Sun Pharma Advanced Research Share Price

Sun Pharma Advanced Research Share Price

NSE: SPARC
|
Diversified

₹ 185.60

-₹2.14 (-1.14%)
1D
Last updated 09 Oct, 2026, 15:52 IST

Sun Pharma Advanced Research Share Price Today

As of 9 Oct 2026, Sun Pharma Advanced Research share price is ₹185.60. The stock opened at ₹188.75, compared to its previous close of ₹187.74. During today's trading session, Sun Pharma Advanced Research share price moved in the range of ₹184.05 to ₹192.06, with an average price of ₹188.06 for the day. Looking at its last 52-week, the stock has touched a low of ₹108.00 and a high of ₹289.00. On the performance front, Sun Pharma Advanced Research share price has increased by 37.88% over the last six months and is up 46.61% on a year-on-year basis.

₹184.05
1.14% down today
₹192.06
1D LOW
1D HIGH

Sun Pharma Advanced Research Returns Calculator

Volume
8,28,265
Average traded price
₹186.81
Last traded time
03:52:12 09 Oct
Last traded quantity
110
Circuit
L
H
₹150.20
₹225.28
52-week
L
H
₹108.00
₹289.00
Mkt Cap Cr
6,097.76
P/E
3.85
P/B
4.55
ROA
72.98%
ROE
116.01%
ROCE
80.89%
Quick Ratio
2.47
EV/EBITDA
4.26
Based on fundamentals, this stock's
Step 3 of 5
Performance
Neutral
SPARC performance is moderate compared to markets
Step 3 of 5
Valuation
Fairly Valued
SPARC appears to be fairly valued compared to its peers
Step 3 of 5
Earnings
Neutral
SPARC earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,27,861.4134.75.0311.19%13.74%17.33%2.3121.68
Divis Laboratories2,54,318.9085.2214.8714.6%15.32%19.56%3.557.8
Torrent Pharmaceuticals1,77,821.9782.4821.154.87%25.49%13.85%0.7538.56
Zydus Lifesciences1,15,111.9424.224.18.57%18.59%17.35%0.9115.3
Laurus Labs1,08,062.4499.1120.3910.38%16.77%16.14%0.6854.28
Cipla1,05,427.1231.423.067.92%11.27%14.95%2.518.19
Mankind Pharma99,064.7347.916.087.36%11.74%13.13%0.7427.05
Dr. Reddy's Laboratories1,00,361.9630.942.595.48%11.07%12.54%1.3515.95
Aurobindo Pharma96,951.1825.462.496.34%9.25%11.76%1.1512.39
Lupin88,805.7116.03.9614.47%23.76%24.88%1.429.84

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About Sun Pharma Advanced Research

Sun Pharma Advanced Research Share Price
ISIN
INE232I01014
Sector Market Cap
₹ 6,097.76 Cr

Sun Pharma Advanced Research Company Limited is an India-based clinical-stage biopharmaceutical company that focuses on developing therapeutics to improve standards of care for patients worldwide. The Company’s therapeutic focus is in the area of oncology, neurology and immunology. Its lead oncology programs include vodobatinib (SCO-088), a BCR-ABL targeting tyrosine kinase inhibitor for refractory chronic myelogenous leukemia, and an anti-MUC-1 antibody-drug conjugate (ADC) with the potential to treat multiple cancers. The Company’s other programs include Sezaby for the treatment of neonatal seizures, Vodobatinib for the treatment of neurodegenerative disorders (SCC-138), Vibozilimod for the treatment of autoimmune disorders (SCD-044), SCD-153 for the treatment of alopecia areata, SBO-154 for multiple cancer indications and SCO-155 for treatment of cancer. SBO-154 is an anti MUC1 ADC being developed for multiple tumor types expressing MUC1.

Sun Pharma Advanced Research Financial Highlights

  • Revenue: Sun Pharma Advanced Research reported revenue of ₹1,890.12 crore in FY26 vs ₹73.56 crore in FY25. It showed an increase of 2,469.49% on a yearly basis.
  • Operating Profit: Sun Pharma Advanced Research reported an operating profit of ₹1,553.01 crore in FY26 vs ₹342.78 crore in FY25. It showed an increase of 553.06% on a year-on-year basis.
  • Net Profit: Sun Pharma Advanced Research reported a net profit of ₹1,553.20 crore in FY26 vs ₹342.51 crore in FY25. It showed an increase of 553.48% on a yearly basis.

Sun Pharma Advanced Research Quarterly Result Highlights

  • Sun Pharma Advanced Research reported revenue of ₹63.58 crore in Jun 2026, compared with ₹1,855.02 crore in Mar 2026, representing a decrease of 96.57% on a quarter-on-quarter (QoQ) basis.
  • Sun Pharma Advanced Research reported an operating loss of ₹20.67 crore in Jun 2026, compared with ₹1,760.96 crore in Mar 2026, representing a decrease of 101.17% on a quarter-on-quarter (QoQ) basis.
  • Sun Pharma Advanced Research reported a loss of ₹20.78 crore in Jun 2026, compared with ₹1,761.34 crore in Mar 2026, reflecting a decrease of 101.18% on a QoQ basis.
  • The earnings per share (EPS) of Sun Pharma Advanced Research stood at ₹47.86 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
65.67%
FII
3.90%
Other DII
0.01%
Retail and other
30.33%
Mutual funds
0.08%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20252.04%
Mar 20262.04%
May 20262.47%
Jun 20263.90%
1 day
-4.60%
1 week
-4.79%
1 month
-7.64%
1 year
+46.61%
3 years
-19.11%
5 years
-35.12%
Day
Open / Close
Change %
08 Oct 26
₹197.00 / ₹187.74
-4.60%
07 Oct 26
₹196.00 / ₹196.79
-0.05%
06 Oct 26
₹192.14 / ₹196.89
+2.94%
05 Oct 26
₹194.56 / ₹191.26
-1.48%
Show more

Sun Pharma Advanced Research Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,879.17₹71.77₹75.55₹238.78
Other Income₹10.95₹1.79₹29.47₹10.88
Total Revenue₹1,890.12₹73.56₹105.01₹249.66
Total Expenses₹324.75₹416.34₹491.85₹472.24
Profit Before Tax₹1,553.01-₹342.78-₹386.83-₹222.58
Tax-₹0.19-₹0.27₹0.38₹0.00
Profit After Tax₹1,553.20-₹342.51-₹387.21-₹222.58
EPS - Basic₹47.86-₹10.55-₹11.93-₹7.82
EPS - Diluted₹47.86-₹10.55-₹11.93-₹7.82

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1,553.01-₹342.78-₹386.83-₹222.58
Income before WC changes₹1,594.17-₹322.26-₹397.74-₹215.59
Change in Assets-₹1,850.30₹2.92-₹47.88₹5.40
Change in Liabilities-₹14.29-₹49.78₹20.54₹135.71
Change in WC-₹1,864.59-₹46.86-₹27.33₹141.11
Cash flow from Operations-₹238.78-₹360.29-₹429.19-₹69.12
Cash flow from Investing-₹23.50₹157.66₹391.53-₹548.28
Cash flow from Financing₹261.39₹199.26₹42.41₹616.76
Total Cash Flow-₹0.89-₹3.38₹4.74-₹0.64
Cash (Start of the year)₹1.96₹5.33₹0.58₹1.22
Cash (End of the year)₹1.16₹1.96₹5.33₹0.58

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹308.45₹309.34₹245.66₹375.16
Current Assets₹1,862.43₹26.20₹269.39₹454.96
Total Assets₹2,170.88₹335.53₹515.04₹830.13
Current Liabilities₹754.11₹374.24₹265.06₹178.95
Net Current Asset₹1,108.32-₹348.04₹4.33₹276.02
Non-Current Liabilities₹77.94₹178.24₹124.23₹138.41
Equity Capital₹1,338.83-₹216.95₹125.76₹512.78
Total Equity & Liabilities₹2,170.88₹335.53₹515.04₹830.13

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,879.17₹71.77₹75.55₹238.78
Other Income₹10.83₹1.79₹29.47₹10.88
Total Revenue₹1,890.00₹73.56₹105.01₹249.66
Total Expenses₹325.50₹418.78₹493.12₹472.24
Profit Before Tax₹1,552.13-₹345.22-₹388.11-₹222.58
Tax₹0.00₹0.00₹0.00₹0.00
Profit After Tax₹1,552.13-₹345.22-₹388.11-₹222.58
EPS - Basic₹47.83-₹10.64-₹11.96-₹7.82
EPS - Diluted₹47.83-₹10.64-₹11.96-₹7.82

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1,552.13-₹345.22-₹388.11-₹222.58
Income before WC changes₹1,593.27-₹326.40-₹399.44-₹215.59
Change in Assets-₹1,850.28-₹19.94-₹25.34₹5.40
Change in Liabilities-₹13.52-₹26.86-₹0.54₹135.71
Change in WC-₹1,863.80-₹46.80-₹25.88₹141.11
Cash flow from Operations-₹238.89-₹362.41-₹429.43-₹69.12
Cash flow from Investing-₹23.51₹157.66₹391.11-₹548.28
Cash flow from Financing₹261.53₹200.88₹42.80₹616.76
Total Cash Flow-₹0.87-₹3.87₹4.48-₹0.64
Cash (Start of the year)₹1.19₹5.06₹0.58₹1.22
Cash (End of the year)₹0.32₹1.19₹5.06₹0.58

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹306.61₹304.02₹239.93₹375.16
Current Assets₹1,861.38₹25.26₹246.41₹454.96
Total Assets₹2,167.99₹329.28₹486.33₹830.13
Current Liabilities₹756.83₹373.72₹243.89₹178.95
Net Current Asset₹1,104.55-₹348.46₹2.52₹276.02
Non-Current Liabilities₹77.58₹176.17₹117.59₹138.41
Equity Capital₹1,333.59-₹220.62₹124.86₹512.78
Total Equity & Liabilities₹2,167.99₹329.28₹486.33₹830.13
* All values are in INR Crore
Qty
Bid
4464
185.6
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 4464
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
1
Neutral
3
Bullish
4
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
40.75
Neutral
ATR (14)
9.15
Neutral
STOCH(9,6)
2.22
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
18.3
Bullish
UO(9)
35.5
Neutral
ROC(12)
-4.26
Bearish
WillR(14)
-97.78
Bullish
Period
Simple value
Exponential vaue
5D
193.36
193.81
10D
198.87
196.08
20D
197.13
197.67
50D
200.49
201.58
100D
213.23
197.89
Volume trend — traded volume by day
9 Oct8L
8 Oct12L
7 Oct10L
6 Oct6L
5 Oct8L
Average9L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Sun Pharma Advanced Research Share Price
Sun Pharma Advanced Research
Diversified
Add Stock
Add Another

Sun Pharma Advanced Research Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.